AdvisorShares Psychedelics ETF—— (—)Compass Pathways—— (—)Definium Therapeutics—— (—)GH Research—— (—)Helus Pharma—— (—)MIRA Pharmaceuticals—— (—)Neuphoria Therapeutics—— (—)Eli Lilly—— (—)Johnson & Johnson—— (—)AbbVie—— (—)Otsuka Pharmaceutical—— (—)Numinus Wellness—— (—)Optimi Health—— (—)PharmAla Biotech—— (—)Enveric Biosciences—— (—)Incannex Healthcare—— (—)Aurora Cannabis—— (—)Cronos Group—— (—)SNDL—— (—)Bright Minds Biosciences—— (—)PharmaTher Holdings—— (—)IM Cannabis—— (—)MariMed—— (—)Vireo Growth—— (—)

Loading prices

Einpresswire

Published November 4, 2026 · Updated November 5, 2026

Jocasta Neuroscience & Diamond Therapeutics to Research Novel Compounds for ...

Read the full story at Einpresswire

non- hallucinogenic psychedelic -inspired compounds designed to ... This press release can be viewed online at: https://www.einpresswire.

Post on X

Share this story

Surfaced by this Google Alert

Psychedelic press release